top of page
Search

Genome-Wide Gene Expression Differences of Lung Cancer Cells modified by Fucoidan from Seaweed

  • Writer: Infinitum Health Team
    Infinitum Health Team
  • Mar 28, 2022
  • 1 min read



Seaweeds to the rescue ... again!! Another remarkable study on fucoidan, from seaweed, in this case, one of our favorite species, Undaria pinnatifida, available in all of the Infinitum Health products.


----------

Fucoidan has received increasing attention in anti-(lung) tumors. However, the effect of

fucoidan on the gene changes of lung cancer cells (LCCs) has not been examined

systematically. Herein, they investigate the effect of fucoidan on the phenotypes of LCCs

and their gene expression by transcriptome sequencing analysis. The phenotypes of LCCs are significantly inhibited by fucoidan. Importantly, compared to LCCs, 1 mg/ml fucoidan has no effect on the phenotypes of normal cells.


Further, 6,930 differentially expressed genes (DEGs) in the transcriptome of LCCs (3,501 up-regulated and 3,429 down-regulated genes) are detected via RNA-sequencing between the fucoidan and control groups.



GeneOntology analysis confirms that DEGs are reflected in DNA replication, cell-substrate junction, regulation of cell cycle phase transition, apoptosis, focal adhesion, cadherin binding, and cell adhesion molecule binding.


Thus, their findings on the transcriptomic level highlight the therapeutic potential of fucoidan for lung cancer treatment.


----------


Pretty remarkable right? Know that more research is needed, but another great step for research in this field!


Cheers to your health,


~ Infinitum Health Team


Reference


Zhao Y, Li X, Zhang H, Yan M, Jia M and Zhou Q (2022) A Transcriptome Sequencing Study on Genome-Wide Gene Expression Differences of Lung Cancer Cells Modulated by Fucoidan. Frontiers in Bioegineering and Biotechnology 10:844924.

doi: 10.3389/fbioe.2022.844924


(pdf available for download below)





 
 
 

Comments


Thanks for subscribing!

Infinitum Health, LLC Logo (Copyright 2021)

Infinitum Health, LLC
Copyright 2024. 
All Rights Reserved

Copyright  2024.  All rights reserved.  Infinitum Health, LLC.  *These statements have not been evaluated by the Food and Drug Administration (FDA) or Federal Trade Commission (FTC).  These products are not intended to diagnose, treat, cure or prevent any disease.  This web site (inclusive of blog articles, email marketing, labeling on products and any reference links) are not to be used as a substitute for medical advice, diagnosis or treatment of any health condition or problem. Users of this web site (inclusive of blog articles, email marketing, labeling on products and any reference links) should not rely on information provided for their own health problems.  Any questions regarding your own health should be addressed to your physician or other healthcare provider.  We provide the research and information and request customers to read through it thoroughly and educate themselves to aid in making an informed and safe decision to buy.  

*If a purchase is made, implied consent is assumed and your email address will be added to our customer list.  Feel free to unsubscribe if you don't want discounts, updates, or research evidence.

Infinitum Health, LLC | an Engholdt Group Company | 1938 W Horsetail Trail, Phoenix, AZ 85085

info@infinitumhealth.com

(623) 251-7951 [for efficient response, we highly recommend email communication]

  • Facebook Social Icon
  • Pinterest Social Icon
  • Twitter Social Icon
  • LinkedIn Social Icon
  • YouTube Social  Icon
bottom of page